Understanding Payer Sensitivities when Considering the Use of Surrogate Endpoints to Substantiate Clinical Value Propositions - Evidera

Understanding Payer Sensitivities when Considering the Use of Surrogate Endpoints to Substantiate Clinical Value Propositions Feature Image

Understanding Payer Sensitivities when Considering the Use of Surrogate Endpoints to Substantiate Clinical Value Propositions